Invention Grant
US07655425B2 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES
失效
使用能够结合MCP-1，MIP-1α和/或RANTES的趋化因子受体
- Patent Title: Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES
- Patent Title (中): 使用能够结合MCP-1，MIP-1α和/或RANTES的趋化因子受体
-
Application No.: US10933356Application Date: 2004-09-03
-
Publication No.: US07655425B2Publication Date: 2010-02-02
- Inventor: Timothy N. C. Wells , Christine A. Power
- Applicant: Timothy N. C. Wells , Christine A. Power
- Applicant Address: GB Greenford Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Greenford Middlesex
- Agent Elizabeth J. Hecht; William T. Han
- Priority: GB9501683.8 19950127
- Main IPC: G01N33/567
- IPC: G01N33/567 ; A61K39/395 ; C07K14/715
Abstract:
A chemokine receptor binds to MCP-1, MIP-1α and/or RANTES. It can be used in screening for agents which act as antagonists to MCP-1, MIP-1α and/or RANTES. Such agents may be useful in treating various disorders, including allergies, atheromas and diseases mediated by viruses. They may also be useful in preventing graft rejection and in protecting stem cells from potentially damaging effects of chemotherapy.
Public/Granted literature
- US20050014695A1 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes Public/Granted day:2005-01-20
Information query
IPC分类:
